Gastric sleeve in Nigeria is an increasingly sought-after option for people living with severe obesity who have not achieved sufficient results through non-surgical means. Sleeve gastrectomy — one of the most commonly performed bariatric procedures worldwide — permanently reduces stomach capacity and influences key hunger hormones, supporting sustained weight loss and improvement in obesity-related conditions such as type 2 diabetes and hypertension. This article covers how the procedure works, who qualifies, what risks to consider, how to access and fund care in Nigeria, and what long-term commitment is required for lasting success.

What Is Gastric Sleeve Surgery and How Does It Work?

Gastric sleeve surgery permanently removes 75–80% of the stomach laparoscopically, creating a narrow tube that restricts food intake and reduces ghrelin levels, thereby limiting appetite and supporting weight loss.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, formally known as sleeve gastrectomy, is a type of bariatric (weight-loss) procedure in which approximately 75–80% of the stomach — including the gastric fundus — is permanently and irreversibly removed, leaving a narrow, tube-shaped 'sleeve' roughly the size and shape of a banana. This significantly reduces the stomach's capacity, limiting the amount of food a person can consume at any one time.

Beyond simple restriction, the procedure also has hormonal effects. The removed portion of the stomach contains the majority of cells responsible for producing ghrelin — often referred to as the 'hunger hormone' — and ghrelin levels typically fall after surgery, which may help reduce appetite in the early post-operative period. However, appetite can return over time, and the procedure also influences other gut hormones involved in satiety and metabolism, such as GLP-1 and PYY, which contribute to its longer-term effects on weight and metabolic health.

The operation is typically performed laparoscopically (keyhole surgery), involving small incisions, a camera, and specialised instruments. This minimally invasive approach generally results in shorter hospital stays, reduced post-operative pain, and faster recovery compared with open surgery. Sleeve gastrectomy is one of the most widely performed bariatric procedures, and is offered at a number of specialist centres in Nigeria. As with all bariatric procedures, it should be considered only as part of a comprehensive, multidisciplinary weight management programme.

Patients considering this procedure should review information from authoritative sources such as the NHS weight loss surgery pages and NICE guideline CG189 (Obesity: identification, assessment and management).

Who Is Eligible for Gastric Sleeve Surgery?

Candidates typically require a BMI of 40 kg/m² or above, or 35 kg/m² with an obesity-related comorbidity, assessed by a multidisciplinary team; lower thresholds may apply for people of Asian family origin.

Eligibility for gastric sleeve surgery is guided by internationally recognised criteria. In the UK, NICE guideline CG189 provides the standard framework, and reputable bariatric centres in Nigeria typically apply similar evidence-based standards.

Generally, candidates may be considered eligible if they meet the following criteria:

• BMI of 40 kg/m² or above, or

• BMI of 35 kg/m² or above with at least one significant obesity-related comorbidity, such as type 2 diabetes, hypertension, obstructive sleep apnoea (OSA), or non-alcoholic fatty liver disease

• BMI of 30–34.9 kg/m² in adults with recent-onset type 2 diabetes, where surgery may be considered as part of their diabetes management (per NICE CG189)

• Lower BMI thresholds may be appropriate for people of Asian family origin, who are at increased metabolic risk at lower BMI values

• Have tried appropriate non-surgical weight management measures (dietary changes, physical activity, behavioural support) — NICE does not specify a fixed minimum duration, but expects these to have been genuinely attempted

• Are aged 18 or above (adolescent cases are assessed individually and require specialist input)

• Are medically fit to undergo general anaesthesia and surgery

Patients are assessed by a multidisciplinary team (MDT) that typically includes a bariatric surgeon, dietitian, psychologist, and physician. This assessment evaluates physical health, psychological readiness, and the patient's understanding that the procedure requires permanent and significant lifestyle changes.

Severe gastro-oesophageal reflux disease (GORD) is an important relative contraindication: sleeve gastrectomy can worsen or precipitate GORD, and in such cases gastric bypass may be the preferred surgical option. Other factors that may preclude surgery include uncontrolled psychiatric illness, active substance misuse, or significant anaesthetic risk. The decision is always made on an individual basis by the MDT.

Pre-operative assessment typically includes blood tests, cardiac evaluation, and — where clinically indicated or per local protocol — upper gastrointestinal endoscopy. Most centres also require a liver-shrinking (low-calorie) diet for approximately two weeks before surgery to reduce liver size and improve operative safety. Patients are strongly advised to stop smoking and minimise alcohol intake well in advance of surgery. Where OSA is identified, assessment and treatment with CPAP (continuous positive airway pressure) may be required before proceeding.

Women of childbearing age should be counselled to use reliable contraception and avoid pregnancy for at least 12–18 months after surgery, as rapid weight loss in the post-operative period carries risks for both mother and baby. Specialist review is recommended before attempting conception.

Risks, Complications and Safety Considerations

Key risks include staple line leak, GORD, nutritional deficiencies, DVT, and weight regain; NSAIDs must be avoided post-operatively, and urgent review is needed for fever, severe pain, or persistent vomiting.

As with any major surgical procedure, gastric sleeve surgery carries both short-term and long-term risks. Understanding these is essential for informed consent and realistic expectation-setting.

Short-term risks include:

• Bleeding or haematoma formation

• Staple line leak — a serious complication where gastric contents escape through the surgical staple line; reported rates vary by centre and patient factors, but are generally cited in the range of 1–3% in published series

• Infection, including wound infection or intra-abdominal abscess

• Deep vein thrombosis (DVT) or pulmonary embolism

• Adverse reactions to anaesthesia

• Thiamine (vitamin B1) deficiency in the context of persistent post-operative vomiting, which can cause serious neurological complications including Wernicke's encephalopathy; early clinical review and thiamine replacement are essential if vomiting is prolonged

Longer-term complications may include:

• Gastro-oesophageal reflux disease (GORD), which can worsen or develop for the first time following sleeve gastrectomy; many centres prescribe a proton pump inhibitor (PPI) for approximately three months post-operatively to reduce ulcer and reflux risk, with ongoing review thereafter

• Nutritional deficiencies, particularly in vitamin B12, iron, vitamin D, folate, and calcium, due to reduced food intake and altered absorption — lifelong supplementation and monitoring are required (see 'Life After Gastric Sleeve' section)

• Gallstone formation, which is more common during periods of rapid weight loss; patients should seek prompt review if they develop symptoms of biliary colic (right upper abdominal pain, particularly after fatty meals)

• Weight regain, particularly if dietary and behavioural changes are not maintained

• Stricture or narrowing of the gastric sleeve

• Hair thinning (telogen effluvium), which is common in the first few months and usually temporary

Patients should avoid non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen after surgery, as these increase the risk of ulceration. Smoking and excess alcohol should also be avoided.

Safety outcomes are closely linked to the experience and accreditation of the surgical team and facility. Patients in Nigeria are strongly advised to seek care at centres with demonstrable bariatric expertise, appropriate intensive care facilities, and robust post-operative follow-up programmes. Prospective patients should ask about annual procedure volumes, complication rates, and access to emergency care.

Red flags — seek urgent medical attention if you experience any of the following after discharge:

• Fever or chills

• Persistent or severe vomiting, or inability to keep fluids down

• Severe or worsening abdominal pain

• Rapid heart rate, chest pain, or breathlessness

• Calf pain or swelling (possible DVT)

• Vomiting blood or passing black, tarry stools

• Signs of wound infection

If you cannot reach your surgical team, attend the nearest emergency department without delay.

If you experience suspected side effects from any medicines, anaesthetic agents, or medical devices used as part of your care, these can be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Costs and Accessing Bariatric Care in Nigeria

Gastric sleeve surgery in Nigeria is available at private hospitals in Lagos, Abuja, and Port Harcourt; costs vary and are not routinely covered by the NHIA, so patients should request a full written cost breakdown before proceeding.

Access to bariatric surgery in Nigeria has grown over the past decade, with a number of private hospitals in major cities — including Lagos, Abuja, and Port Harcourt — now offering sleeve gastrectomy and other weight-loss procedures. However, availability remains largely confined to private healthcare settings. Bariatric surgery is not routinely covered under the National Health Insurance Authority (NHIA) scheme for most patients, though individuals should verify current policy directly with the NHIA or their insurer, as coverage arrangements may change.

The cost of gastric sleeve surgery in Nigeria varies considerably depending on the hospital, the surgeon's experience, the extent of pre-operative investigations required, and the length of hospital stay. Costs are subject to change and should be confirmed directly with the treating centre; published figures can become outdated quickly. Patients should request a full written breakdown of what is included — for example, whether nutritional supplements, follow-up consultations, psychological support, and management of early complications are covered within the quoted fee.

For those considering travelling abroad for surgery — sometimes referred to as 'medical tourism' — it is important to carefully evaluate the credentials of overseas providers, the quality of post-operative follow-up available upon return to Nigeria, and the logistical challenges of managing complications at a distance. Patients should seek centres accredited by recognised international bodies, such as the Joint Commission International (JCI) or those recognised within IFSO's Centre of Excellence framework. Comprehensive travel and medical insurance that explicitly covers surgical complications and, if necessary, medical evacuation is strongly advised before travelling for any procedure.

Prospective patients are encouraged to:

• Request a full written breakdown of costs and what is included before committing

• Verify the surgeon's qualifications and specific bariatric experience

• Confirm the facility has appropriate critical care support

• Ensure clear arrangements are in place for long-term nutritional, medical, and psychological follow-up

• Obtain appropriate insurance cover, particularly if travelling abroad for surgery

Life After Gastric Sleeve: Recovery and Long-Term Outcomes

Most patients are discharged within two to three days and progress through a structured diet over six to eight weeks; lifelong nutritional supplementation, regular blood monitoring, and sustained lifestyle changes are essential for long-term success.

Recovery from gastric sleeve surgery is generally well-tolerated when patients are appropriately selected and supported. Most individuals are discharged from hospital within two to three days following laparoscopic surgery, though this varies by individual circumstance. During the initial weeks, patients progress through a structured dietary programme — beginning with clear fluids, advancing to puréed foods, and gradually reintroducing soft and then solid foods over approximately six to eight weeks.

In terms of weight loss, patients can typically expect to lose around 50–60% of their excess body weight over the first one to two years following surgery, though outcomes vary between individuals depending on adherence to lifestyle changes, pre-operative health status, and follow-up engagement. Many obesity-related comorbidities — including type 2 diabetes, hypertension, and sleep apnoea — show significant improvement or complete resolution in a substantial proportion of patients, contributing to meaningful improvements in quality of life and long-term health.

However, long-term success depends heavily on sustained lifestyle modification. Key commitments include:

• Dietary adherence: eating small, nutrient-dense meals; avoiding high-sugar and high-fat foods; chewing thoroughly; not drinking fluids immediately before or after meals

• Regular physical activity: gradually increasing exercise as recovery progresses

• Nutritional supplementation: lifelong supplementation is required and should be guided by your bariatric team. This typically includes a bariatric-specific multivitamin and mineral supplement, calcium with vitamin D, and iron where indicated. Vitamin B12 levels should be monitored and supplemented — often via intramuscular injection depending on levels — as oral absorption may be unreliable. Supplementation regimens should follow current guidance such as that from the British Obesity and Metabolic Surgery Society (BOMSS)

• Avoiding NSAIDs and smoking: these increase the risk of ulceration and other complications; alcohol should be consumed only in moderation, if at all, as sensitivity increases after surgery

• Ongoing follow-up and blood monitoring: regular review with a multidisciplinary team is essential. Blood tests are typically recommended at approximately 3, 6, and 12 months post-operatively, and then annually. These should include full blood count, ferritin, folate, vitamin B12, vitamin D, calcium, parathyroid hormone (PTH), and liver function tests, with consideration of trace elements (zinc, copper, selenium) where clinically indicated. Bone health should be monitored over the longer term

• PPI review: many centres prescribe a proton pump inhibitor for approximately three months post-operatively; the ongoing need should be reviewed with your clinical team

Weight regain is possible, particularly beyond five years, if behavioural changes are not maintained. Patients who engage consistently with follow-up care and support groups tend to achieve the best long-term outcomes.

Women should avoid pregnancy for at least 12–18 months after surgery and should seek specialist review and nutritional optimisation before attempting conception.

Anyone experiencing significant weight regain, nutritional symptoms, persistent reflux, or other concerns following surgery should seek prompt review from their bariatric team. Further information on aftercare is available from the NHS weight loss surgery pages and BOMSS patient resources.

Frequently Asked Questions